The table below shows Bioventus Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$568.09M
$573.28M
$512.35M
$512.12M
$430.90M
$321.16M
Cost of revenue
$179.93M
$185.05M
$184.15M
$181.04M
$128.19M
$87.64M
Gross profit
$388.16M
$388.23M
$328.19M
$331.08M
$302.71M
$233.52M
R&D
$12.11M
$13.95M
$13.45M
$23.85M
$19.04M
$11.20M
BVS annual revenue (10-K history)
Bioventus Inc. reported annual revenue of $568.09M for fiscal year 2025. That is down 0.9% from $573.28M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $340.14M (FY 2019) to $568.09M. Figures come from the company's audited annual reports as filed with the SEC.